- Filed
- Nov 10, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Oct 31, 2025 | 48.73M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 48.73M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 48.47M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 47.56M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 47.42M sh |
| Stock Repurchased | Q3 2025 · Sep 30, 2025 | $695K |
| Stock Repurchased | Q3 2025 · Sep 30, 2024 | $1.68M |
| Capex | Q3 2025 · Sep 30, 2025 | $13.27M |
| Capex | Q3 2025 · Sep 30, 2024 | $22.08M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | −$114.83M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2024 | −$74.84M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $29.5M |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $143.3M |
| Cash And Equivalents restated | Q3 2025 · Sep 30, 2024 | $80.91M |
| Cash And Equivalents restated | Q3 2025 · Dec 31, 2023 | $119.89M |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | −$582.83M |
| Stockholders Equity | Q3 2025 · Jun 30, 2025 | −$485.44M |
| Stockholders Equity | Q3 2025 · Mar 31, 2025 | −$420.69M |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | −$373.24M |
| Stockholders Equity | Q3 2025 · Sep 30, 2024 | −$322M |
| Stockholders Equity | Q3 2025 · Jun 30, 2024 | −$274.26M |
| Stockholders Equity | Q3 2025 · Mar 31, 2024 | −$184.07M |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | −$122.3M |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $584.24M |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $473.97M |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $963.7M |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $1.07B |
| Current Assets | Q3 2025 · Sep 30, 2025 | $183.59M |
| Current Assets | Q3 2025 · Dec 31, 2024 | $429.1M |
| Total Assets | Q3 2025 · Sep 30, 2025 | $380.87M |
| Total Assets | Q3 2025 · Dec 31, 2024 | $692.46M |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$2.63 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$5.05 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | −$0.84 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | −$4.06 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$2.63 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$5.05 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | −$0.84 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | −$4.06 |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $7.04M |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $24.83M |
| Sga Expense restated | Q3 2025 · Sep 30, 2024 | $9.82M |
| Sga Expense restated | Q3 2025 · Sep 30, 2024 | $36.98M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$128.16M |
| Net Income | Q3 2025 · Jun 30, 2025 | −$68.23M |
| Net Income | Q3 2025 · Mar 31, 2025 | −$48.31M |
| Net Income | Q3 2025 · Sep 30, 2024 | −$40.07M |
| Net Income | Q3 2025 · Jun 30, 2024 | −$91.09M |
| Net Income | Q3 2025 · Mar 31, 2024 | −$61.47M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$80.35M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$144.15M |
| Operating Income restated | Q3 2025 · Sep 30, 2024 | −$18.7M |
| Operating Income restated | Q3 2025 · Sep 30, 2024 | −$102.84M |
| Gross Profit | Q3 2025 · Sep 30, 2025 | −$46.54M |
| Gross Profit | Q3 2025 · Sep 30, 2025 | −$84.73M |
| Gross Profit restated | Q3 2025 · Sep 30, 2024 | $174K |
| Gross Profit restated | Q3 2025 · Sep 30, 2024 | −$52.85M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $280.95M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $796.86M |
| Cost Of Revenue restated | Q3 2025 · Sep 30, 2024 | $259M |
| Cost Of Revenue restated | Q3 2025 · Sep 30, 2024 | $716.2M |
| Revenue | Q3 2025 · Sep 30, 2025 | $234.41M |
| Revenue | Q3 2025 · Sep 30, 2025 | $712.14M |
| Revenue restated | Q3 2025 · Sep 30, 2024 | $259.17M |
| Revenue restated | Q3 2025 · Sep 30, 2024 | $663.36M |